Polyamino acids, particularly the amalgamation with Poly(lactic-co-glycolic acid) (PLGA), represent a cutting-edge frontier in the realm of drug delivery. This innovative combination harnesses the unique attributes of polyamino acids and the versatility of PLGA, offering a synergistic platform for advanced therapeutic strategies. Polyamino acids, being inherently biocompatible and exhibiting minimal immunogenicity, complement the biodegradable nature of PLGA, resulting in a biomaterial conducive to tailored drug release.
The marriage of Polyamino Acids-PLGA holds promise for overcoming challenges associated with conventional drug delivery systems. The tunable properties of PLGA allow for precise modulation of degradation rates, influencing the sustained and controlled release of therapeutic agents. Moreover, the amino acid components introduce an added dimension, facilitating targeted drug delivery and potentially enhancing cellular uptake.
Catalog: PBPG3
MW: PLGA optional molecular weight: 1000 2000 5000 10000 15000 20000 40000 PGA molecular weight optional: 1600 2500 4800 7400 12000 16000 24000 33000 48000
Catalog: PBPG1
MW: PLGA optional molecular weight: 1000 2000 5000 10000 15000 20000 40000 PGA molecular weight optional: 1600 2500 4800 7400 12000 16000 24000 33000 48000
Catalog: PBPL2
MW: PLGA optional molecular weight: 1000 2000 5000 10000 15000 20000 40000 PLL molecular weight optional: 1600 2500 4800 7400 12000 16000 24000 33000 48000
Catalog: PBPL3
MW: PLGA optional molecular weight: 1000 2000 5000 10000 15000 20000 40000 PLL molecular weight optional: 1600 2500 4800 7400 12000 16000 24000 33000 48000
Catalog: PBPL1
MW: PLGA optional molecular weight: 1000 2000 5000 10000 15000 20000 40000 PLL molecular weight optional: 1600 2500 4800 7400 12000 16000 24000 33000 48000